Clinical Trial Update: Biweekly Docetaxel in Patients With Metastatic Breast Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating biweekly docetaxel in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Centro Universitario contra el Cáncer | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED